WHO REALLY CONTROLS THE GOLD PRICE?? The Answer is Quite Surprising

https://srsroccoreport.com/who-really-controls-the-gold-price-the-answer-is-quite-surprising/

WHO Warns Ebola Outbreak Out Of Control, "High Risk Of Spread To Other Countries"

http://www.zerohedge.com/news/2014-08-01/who-warns-ebola-outbreak-out-control-high-risk-spread-other-countries

Who Is Going To Buy Our Debt If This War Causes China, Russia And The Rest Of The World To Turn On Us?

As usual, the war-mongers don't have a f***ing clug on the unintended consequences of the US unilaterally attacking Syria.  By doing so, the US would bury its own economy and collapse the global banking system.  It would be 2008 times ten.

The US itself would be a post-industrial, fourth world country if that were to happen.  In other words, we would become the poor bastards who we conveniently label third-world middle Eastern and African countries--a banana republic which perpetually issues sovereign debt which will never be repaid.

http://theeconomiccollapseblog.com/archives/who-is-going-to-buy-our-debt-if-this-war-causes-china-russia-and-the-rest-of-the-world-to-turn-on-us

Who does Bill Gross read?

This tweet will be meaningless to 99.9% of the population.  Here is my breakdown, which will hopefully reduce the gap.

Bill Gross is a genius, who happens to run the largest bond investor in the world, PIMCO--with over $2 trillion of assets under management.

"Durden" is the pseudonym of zero hedge's founder.  It refers to "Tyler Durden", the character played by Brad Pitt in the feature film "Fight Club."  Zero hedge is a blog known for its insightful, if irreverent tone towards government, the banking class, mainstream media, and zombified masses. 

Previously, their critics would label them fringe conspiracy theorists.  The only problem is they also happened to be prescient in predicting financial crises and exposing financial corruption.

The irony is you have one entity which represents the ruling financial elite, and one which includes alternative financial viewpoints--a blog which is admittedly anti-establishment.  That they share the same ideology should concern the dumbed-down and brain-washed investing public.

Gross: Strategists/writers I follow? Dalio, Durden, Bianco, Arnott, Aitken, Santelli, Grant, Grantham, Inker, Marks, Quaintenance & Brodsky
— PIMCO (@PIMCO) August 9, 2013

The Price Smash – Who, What, How and Why?

http://www.silverseek.com/commentary/price-smash-%E2%80%93-who-what-how-and-why-10991

Who Should Be Giving Thanks This Thanksgiving?

http://azizonomics.com/2012/11/22/who-should-be-giving-thanks-this-thanksgiving/

Swine flu plays resurface ahead of next FDA vaccine meeting

BioCryst Pharmaceuticals (BCRX) gapped up again 22% from yesterday's close of $6.21 to $7.58 today, up 22%, while Hemispherx Biopharmaceuticals surged almost 33% from $2.49 to $3.31. Both are up triple digits since we bought them in May (see June 4, 2009 "Swine flu revisited" blog).

BCRX's Peramivir is an effective intravenous anti-viral against seasonal flu, avian flu, and the latest swine flu (H1N1), shown to reduce flu symptoms in Phase III trials conducted by Japanese partner Shionogi. BCRX is also waiting for Emergency Use Authorization (EUA) by the FDA for severe cases requiring hospitalization. The EUA is required since Peramivir is not approved by the FDA. Peramivir has shown at least equal efficacy against the flu when compared to Roche's Tamiflu anti-viral in clinical trials.

HEB is having a conference call tomorrow to update the investment and medical communities on their clinical developments for Ampligen, a flu adjuvant. Studies have been performed worldwide for use of Ampligen as a booster alongside existing vaccines. Ampligen is also under FDA review for approval as a treatment for Chronic Fatigue Syndrome.

Novavax (NVAX) ended today's session at $3.19, up from $3.02. They also named John Trizzino Senior VP of International and Government alliances, in a sign that they are intensifying efforts with government agencies worldwide on getting approved for their vaccine-line particle (VLP) platform. With VLP, the time to manufacture a vaccine is cut in half--approximately 10-12 weeks, and yields are higher because they don't require egg-based cultures. Fixed costs are also lower due to disposable manufacturing systems.

This Thursday, July 23, the FDA Vaccine and Related Biological Products Advisory Committee will meet with vendors to discuss vaccines against the H1N1 virus: http://www.fda.gov/AdvisoryCommittees/Calendar/ucm170908.htm

This meeting is a sequel to the National Biodefense Science Board (NBSB) meeting held last month (see July 20, 2009 "BCRX potential" blog). The questions held at the NBSB will hopefully be answered this Thursday during the FDA Vaccine AC meeting. Shares of all 3 aforementioned companies jumped in anticipation of positive results.

As mentioned in previous blogs, the World Health Organization (WHO) raised the pandemic alert in June to Phase 6--the highest level possible, which last occurred 41 years ago. The foregone conclusion is that the H1N1 is spreading faster than previous pandemic flus. By the time it hits the US hard in the fall, it is estimated that 1 out of 3 Americans will contract the virus. So far, the mortality rate is lower than the avian flu, but should it mutate, the result strains could increase the severity as well as the virulence.

Phase 6 pandemic alert for swine flu?

According to several news sources, World Health Organization's (WHO) Margaret Chan may declare a Phase 6 pandemic alert for the H1N1 virus today in Geneva. It is spreading rapidly in other continents besides north America, which should result in the pandemic alert upgrade.

The virus is spreading in the southern hemisphere during its winter season, and Australia is experiencing rapid infection rates. It should hit the northern hemisphere especially hard in the fall, although Canada has had a huge jump in cases already. The concern is that there are many more unconfirmed cases, as authorities are no longer undergoing extensive testing.

The avian virus (H5N1) is far more lethal, with a 60% mortality rate, while the H1N1 is virulent, if not as lethal. H1N1 human to human transmission is quickly spreading across borders, and medical authorities are concerned that a mutation of the season flu, avian flu, or swine flu could make new strains virulent AND lethal.

A Phase 6 pandemic alert will restrict trade and travel, further deteriorating world economies, but it may be necessary to control the spread of these flu viruses. It will take a massive cooperative effort from medical agencies worldwide to control the spread of these potentially deadly viruses. Stay healthy.

Swine flu (H1N1) redux

http://twitter.com/CDCemergency/status/1764973395

WHO map of H1N1 virus incidents:

http://www.who.int/csr/don/h1n1_20090519_0600.jpg

Is the swine flu scare over?

Apparently not, as the World Health Organization (WHO) is contemplating raising the pandemic alert from phase 5 to phase 6, the highest level. The Influenza A(H1N1) virus is rapidly spreading throughout multiple countries, and is now mutating to the point where there is human-to-human transmission. Roche's Tamiflu and GSK's Relenza are stockpiled in the US, but Tamiflu is potentially ineffective against new mutations, and Relenza may only be marginally effective in combating the virus.

Hence, I invested in another clinical company which has developed a vaccine which has been proven effective in Phase III and Phase II trials in Japan and the US, respectively. They already have existing contracts with government agencies, and negotiations are underway to roll out doses for hospital use and for stockpiling. Unfortunately, this swine flu pandemic is not going away any time soon.